Gejyo F - Search Results

1

A new therapeutic approach to dialysis amyloidosis: intensive removal of beta 2-microglobulin with adsorbent column.

Gejyo F, Homma N, Hasegawa S, Arakawa M. Gejyo F, et al. Artif Organs. 1993 Apr;17(4):240-3. doi: 10.1111/j.1525-1594.1993.tb00574.x. Artif Organs. 1993. PMID: 8498903

2

Arresting dialysis-related amyloidosis: a prospective multicenter controlled trial of direct hemoperfusion with a beta2-microglobulin adsorption column.

Gejyo F, Kawaguchi Y, Hara S, Nakazawa R, Azuma N, Ogawa H, Koda Y, Suzuki M, Kaneda H, Kishimoto H, Oda M, Ei K, Miyazaki R, Maruyama H, Arakawa M, Hara M. Gejyo F, et al. Artif Organs. 2004 Apr;28(4):371-80. doi: 10.1111/j.1525-1594.2004.47260.x. Artif Organs. 2004. PMID: 15084199 Clinical Trial.

3

[Diagnosis of and therapy for patients with dialysis amyloidosis].

Homma N, Gejyo F. Homma N, et al. Among authors: gejyo f. Nihon Rinsho. 2004 Jun;62 Suppl 6:348-52. Nihon Rinsho. 2004. PMID: 15250322 Review. Japanese. No abstract available.

4

New type of amyloidosis. a). beta 2-Microglobulin and hemodialysis.

Gejyo F, Arakawa M. Gejyo F, et al. Intern Med. 1993 Dec;32(12):925-7. doi: 10.2169/internalmedicine.32.925. Intern Med. 1993. PMID: 8204972 Free article. No abstract available.

5

Long-term complications of dialysis: pathogenic factors with special reference to amyloidosis.

Gejyo F, Homma N, Arakawa M. Gejyo F, et al. Kidney Int Suppl. 1993 Jun;41:S78-82. Kidney Int Suppl. 1993. PMID: 8320951 Review.

6

Learning from the Japanese Registry: how will we prevent long-term complications? Niigata Research Programme for beta 2-M Removal Membrane.

Aoike I, Gejyo F, Arakawa M. Aoike I, et al. Among authors: gejyo f. Nephrol Dial Transplant. 1995;10 Suppl 7:7-15. doi: 10.1093/ndt/10.supp7.7. Nephrol Dial Transplant. 1995. PMID: 8570083 Clinical Trial.

7

131I-beta 2-microglobulin scintigraphy in patients with dialysis amyloidosis.

Gejyo F, Kazama JJ, Hasegawa S, Nishi S, Arakawa M, Odano I. Gejyo F, et al. Clin Nephrol. 1995 Nov;44 Suppl 1:S14-8. Clin Nephrol. 1995. PMID: 8608655

8

Long-term clinical evaluation of an adsorbent column (BM-01) of direct hemoperfusion type for beta 2-microglobulin on the treatment of dialysis-related amyloidosis.

Gejyo F, Teramura T, Ei I, Arakawa M, Nakazawa R, Azuma N, Suzuki M, Furuyoshi S, Nankou T, Takata S, et al. Gejyo F, et al. Artif Organs. 1995 Dec;19(12):1222-6. doi: 10.1111/j.1525-1594.1995.tb02289.x. Artif Organs. 1995. PMID: 8967878 Clinical Trial.

9

Synovial inflammatory cells captured 131I-beta 2-microglobulin in patients with dialysis related amyloidosis.

Kazama JJ, Arakawa M, Gejyo F. Kazama JJ, et al. Among authors: gejyo f. Amyloid. 1998 Mar;5(1):24-9. doi: 10.3109/13506129809007286. Amyloid. 1998. PMID: 9547002

10

Cystic radiolucencies of carpal bones, distal radius and ulna as a marker for dialysis-associated amyloid osteoarthropathy.

Homma N, Gejyo F, Kobayashi H, Saito H, Sakai S, Suzuki M, Hirasawa Y, Arakawa M. Homma N, et al. Among authors: gejyo f. Nephron. 1992;62(1):6-12. doi: 10.1159/000186986. Nephron. 1992. PMID: 1436294

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

547 results

Search Page

Filters